Protagonist Therapeutics, Inc Long Term Debt

Quick Answer

Protagonist Therapeutics, Inc reported Long Term Debt of $9.79 million for the year ending 2019.

  • This data is from Protagonist Therapeutics, Inc's annual report (Form 10-K), filed with the SEC on March 10, 2021.
  • XBRL data for this metric is available from 2019 to 2019 (1 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q1 2020: $9.83 million.
  • Data sourced from SEC EDGAR public filings as of August 7, 2026.

Last verified: